期刊文献+

癌症疫苗研究进展

Research progress on the cancer vaccine
原文传递
导出
摘要 随着免疫学机制的深入研究和生物技术的迅速发展,预防、治疗癌症成为疫苗学研究领域新的发展方向。本文综述了近年来癌症疫苗的研究进展情况。 As the immunological and biological technology developing quickly,preventive and therapeutic cancer vaccine have become one of the focus in vaccinology.The author overviewed the research progress on the cancer vaccine in recent years.
作者 李娟 李长贵
出处 《药物分析杂志》 CAS CSCD 北大核心 2010年第10期1972-1975,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 癌症疫苗 cancer vaccine
  • 相关文献

参考文献21

  • 1FUTURE Ⅱ Study Group, Quadrivalent vaccine against Human Papillomavirus to prevent high - grade cervical lessions. N Engl J Med ,2007,356 ( 19 ) : 1915.
  • 2Olsson SE, Villa LL, Costa RLR, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus - like particle (VLP) vaccine. Vaccine,2007 (25) :4931.
  • 3Harris JE,Ryan L, Hoover Jr HC, et al. Adjuvant active specific immunotherapy for stage Ⅱ and Ⅲ colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Orwol,2000,18 ( 1 ) : 148.
  • 4Berd D, Maguire Jr HC, Mastrangelo M J, et al. Treatment of human melanoma with a hapten - modified autologous vaccine. Ann NY Acad Sci,1993,690(8) :7.
  • 5Remann R, Goldschmidt AJ, Richter A. Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine : a - year - follow - up analysis. Anticancer Res ,2003 ,23 ( 2 A ) : 969.
  • 6Mitchell MS, Kan - Mitchell J, Kempf RA, et al. Active specific immunotherapy for melanoma:phase Ⅰ trial of allogeneic lysates and a novel adjuvant. Cancer Res, 1988,48 (20) :5883.
  • 7Michael A, Ball G, Quatan N, et al. Delayed disease progression after allogeneic cell vaccine in hormone - resistant prostate cancer and correlation with immunologic variables. Clin Cancer Res, 2005,11 ( 12 ) :4469.
  • 8Morton DL, Hsueh EC, Essner R, et al, Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after resection of melanoma metastatic to regional lymphnodes. Ann Surg,2002,236( 4 ) :438.
  • 9Sondak VK, Sabel MS, Mul' e JJ. Allogeneic and qutologous melanoma vaccine:where have we been and where are we going Clin Cancer Res,2006,12( 7 Pt2) :2337s.
  • 10Renard V, Sonderbye L, Ebbehoj K,et al. HER - 2 DNA and protein vaccine containing potent Th cell epitopes induce distinct protective and therapeutic antitumor responses in HER -2 transgenic mice. J Immunol,2003,171 ( 3 ) : 1588.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部